MD6a is a melatonin derivative with inhibitory activity against poly(ADP-ribose) polymerase (PARP-1). It maintains protein homeostasis and improves mitochondrial function via the TOR/HSF-1 signaling pathway, providing neuroprotective effects.
Formula:
C21H22N2O2
Target:
PARP
* VAT and and shipping costs not included. Errors and price changes excepted
